Product Program year 2025 Source: CMS Open Payments

Xelpros

Drug Ophthalmology

NDC 47335-317-90

Open in the dashboard

General payments

$785,181

35,208 payments

Research payments

$0

0 payments

Through program year 2025, $785,181 in general payments and $0 in research payments were reported against Xelpros (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $42,190 376
2024 General $40,497 457
2023 General $37,988 1,371
2022 General $164,371 7,086
2021 General $219,095 11,572
2020 General $108,142 5,559
2019 General $172,899 8,787

Breakdown

Who paid General payments · program years 2019–2025
  1. Sun Pharmaceutical Industries Inc. $785,181 35,208 payments
Top recipients General payments · program year 2025
  1. Ranjan Malhotra Ophthalmology · Saint Louis, MO $2,400 6% · 2 payments
  2. Jason Bacharach Glaucoma Specialist · Petaluma, CA $2,325 6% · 3 payments
  3. Gregory Katz Ophthalmology · Ypsilanti, MI $2,310 5% · 3 payments
  4. Lisa Feulner Bel Air, MD $2,250 5% · 1 payment
  5. Joseph Thimons Optometrist · Fairfield, CT $1,800 4% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Optometrist $23,776 60% · 135 practitioners
  2. Ophthalmology $10,603 27% · 57 practitioners
  3. Glaucoma Specialist Ophthalmology $2,605 7% · 5 practitioners
  4. Dermatology $1,800 5% · 1 practitioner
  5. Optometrist, Corneal and Contact Management Optometrist $305 <1% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $6,503 15% · 32 recipients
  2. Arizona $3,245 8% · 60 recipients
  3. Missouri $3,212 8% · 7 recipients
  4. Indiana $2,895 7% · 9 recipients
  5. Michigan $2,542 6% · 3 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

35,208 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record